Project ACCEPT: Engaging Newly Diagnosed HIV+ Youth in Care
The proposed study is a two-group randomized repeated measures design that will examine the efficacy of Project ACCEPT (Adolescents Coping, Connecting, Empowering and Protecting Together) to improve engagement in care among youth newly diagnosed with HIV at five AMTU sites across the United States. Youth will be randomized into one of two study arms; Project ACCEPT, the intervention, or HEALTH, the health education attention-controlled comparison condition. Both arms consist of two individual sessions followed by six group sessions and a final individual session which is expected to take approximately nine weeks after which youth will have four follow-up visits at the following time points:
- post intervention (immediately after the last session);
- 3 months post the last session;
- 6 months post the last session; and
- 12 months post the last session. The trial will be repeated in up to three waves.
HIV Positive Youth That Are Newly Engaged in Care.
Behavioral: Project ACCEPT
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
|Official Title:||Project ACCEPT: Engaging Newly Diagnosed HIV+ Youth in Care|
- Examine the efficacy of Project ACCEPT compared with an attention-controlled health education comparison intervention [ Time Frame: 3 years ] [ Designated as safety issue: No ]Conduct a randomized controlled trial to examine the efficacy of Project ACCEPT compared with an attention-controlled health education comparison intervention (HEALTH). The goals of the intervention are to improve engagement in care, decrease psychosocial barriers to care, and decrease sexual risk for youth newly diagnosed with HIV.
- Explore the relationship between HIV biomarkers and participant's level of engagement in care [ Time Frame: 3 years ] [ Designated as safety issue: No ]Explore the relationship between HIV biomarkers (i.e., CD4 and viral load) and participant's level of engagement in care.
|Study Start Date:||January 2013|
|Estimated Study Completion Date:||January 2016|
|Estimated Primary Completion Date:||January 2016 (Final data collection date for primary outcome measure)|
Experimental: Project ACCEPT
Participants randomized to the intervention (Project ACCEPT) arm.
Behavioral: Project ACCEPT
The intervention, Project ACCEPT, combines weekly individual and group sessions that address a range of issues that impact engagement in care for youth living with HIV, including stigma, disclosure, health relationships, substance use, and future life plans.
Other Name: Adolescents Coping, Connecting, Empowering and Protecting Together
Active Comparator: HEALTH
Participants randomized to the comparison (HEALTH) arm.
The comparison condition, HEALTH, matches Project ACCEPT in number of sessions and duration. The weekly sessions will cover information on alcohol, drugs, HIV and other sexually transmitted diseases (STDs) to meet the ethical responsibility to provide risk reduction information to youth assigned.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01751620
|Contact: Sarah Thornton, BS||(240) firstname.lastname@example.org|
|United States, Florida|
|University of Miami School of Medicine||Recruiting|
|Miami, Florida, United States, 33101|
|Contact: Donna Maturo, MSN 305-243-3442 email@example.com|
|Principal Investigator: Larry Friedman, MD|
|United States, Illinois|
|Stroger Hospital and the CORE Center||Recruiting|
|Chicago, Illinois, United States, 60612|
|Contact: Kelly Bojan, DNP 312-572-4571 firstname.lastname@example.org|
|Principal Investigator: Jaime Martinez, MD|
|United States, Michigan|
|Wayne State University||Recruiting|
|Detroit, Michigan, United States, 48201|
|Contact: Monique L Green-Jones, MPH 313-966-9763 email@example.com|
|Contact: Charnell Cromer, MSN 313-966-0622 firstname.lastname@example.org|
|Principal Investigator: Elizabeth Secord, MD|
|United States, Tennessee|
|St. Jude Childrens Research Hospital||Recruiting|
|Memphis, Tennessee, United States, 38105|
|Contact: Mary Dillard, BSN 901-595-4083 email@example.com|
|Principal Investigator: Aditya Gaur, MD|
|Study Chair:||Sybil Hosek, PhD||Adolescent Trials Network|
|Study Chair:||Gary Harper, PhD||Adolescent Trials Network|